The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The evolution of the education module for men with metastatic prostate cancer (mPC) in the prostate cancer supportive care (PCSC) program.
 
Jennifer Marie Rauw
No Relationships to Disclose
 
Sunil Parimi
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen; Merck; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer
 
Nikita Ivanov
No Relationships to Disclose
 
Jessica Noble
No Relationships to Disclose
 
Eugenia Wu
No Relationships to Disclose
 
Monita Sundar
Honoraria - TerSera
 
Jennifer Goulart
No Relationships to Disclose
 
Celestia S. Higano
Employment - CTI BioPharma Corp (I)
Stock and Other Ownership Interests - CTI BioPharma Corp (I)
Honoraria - Astellas Pharma
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Blue Earth Diagnostics; Carrick Therapeutics; Clovis Oncology; Ferring; Genentech; Hinova Pharmaceuticals; Janssen; Menarini; Merck Sharp & Dohme; Myovant Sciences; Novartis; Pfizer
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); eFFECTOR Therapeutics (Inst); Emergent BioSolutions (Inst); Ferring (Inst); Medivation (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Carrick Therapeutics; Janssen Oncology; Merck Sharp & Dohme; Novartis; Pfizer